Tevogen Inc
TVGN
56 hedge funds and large institutions have $6.04M invested in Tevogen Inc in 2025 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 12 reducing their positions, and 5 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 12
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
45% more capital invested
Capital invested by funds: $4.16M → $6.04M (+$1.88M)
8% more funds holding
Funds holding: 52 → 56 (+4)
0.42% more ownership
Funds ownership: 2.2% → 2.62% (+0.42%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$724K |
| 2 |
Morgan Stanley
New York
|
+$94.6K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$63.4K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$57.3K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$56.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$117K |
| 2 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$63.5K |
| 3 |
JP Morgan Chase
New York
|
-$57.5K |
| 4 |
CF
Corebridge Financial
Houston,
Texas
|
-$12.3K |
| 5 |
SP
SIH Partners
Wilmington,
Delaware
|
-$11.4K |
TVGN Hedge Fund Activity: Q2 2025 in Review
56 of the 7,613 institutional investors tracked by Wall St. Rank reported a position in Tevogen Inc (TVGN) for Q2 2025, worth a combined $6.04M — up 45% from $4.16M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new TVGN positions and 5 closed out — a net gain of 4 holders — while 24 added to existing stakes and 12 trimmed.
The largest buyer was BlackRock, adding an estimated $724K. The largest seller was UBS Group, cutting an estimated $117K.
- 56 institutional investors held Tevogen Inc (TVGN) as of Q2 2025, up from 52 in Q1 2025.
- Funds reported $6.04M of Tevogen Inc stock for Q2 2025, up 45% quarter-over-quarter.
- 9 funds opened new Tevogen Inc positions in Q2 2025 and 5 closed out, a net change of +4 holders.
- The largest Tevogen Inc buyer in Q2 2025 was BlackRock, an estimated $724K added.
- The largest Tevogen Inc seller in Q2 2025 was UBS Group, an estimated $117K sold.
Based on aggregated 13F filings for Q2 2025.